Printer Friendly

Tokyo District Court Dismisses Ajinomoto's Patent Infringement Case against Chugai Pharmaceutical.

Tokyo, Japan, Mar 22, 2006 - (JCN) - Chugai Pharmaceutical announced on March 22 that the Tokyo District Court has dismissed a patent infringement case against the company, which was filed by Ajinomoto on April 20, 2004.

Ajinomoto alleged that Chugai Pharmaceutical had infringed upon its patent in the process of manufacturing Epogin and Neutrogin, two ethical drugs marketed by Chugai Pharmaceutical.

Accordingly, Ajinomoto sought 3 billion yen ($25.4 mil) and statutory interest as compensation for the damage. The Japanese Patent Office (JPO) had already declared the relevant patent invalid as of September 2005.

Currently, the revocation suit against the JPO decision is pending at the Intellectual Property High Court.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Mar 27, 2006
Words:119
Previous Article:Lawson to Recycle Cooking Oil at All Stores.
Next Article:RIKEN Research Center for Allergy and Immunology Discovers Mechanism for Regulating Immune Response.


Related Articles
Jury finds for Cadence in patent suit: mentor to challenge rulings. (Design).
How much is an innovative engineer worth?
Gypsum disagreement settled.
Takeda Pharmaceutical Wins Patent Infringement Case on ACTOS in US.
Eisai Lawsuit Against Generic Drug Manufacturers Dismissed.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters